Abrahamsen, Greger <br/><br/>
A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations.  [electronic resource] 

 -  Disease models & mechanisms  Mar 2013 
 - 489-502 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1754-8411 
<br/><br/><label>Standard No.: </label>10.1242/dmm.010884  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Adenosine Triphosphatases--genetics<br/>Adult<br/>Aged<br/>Case-Control Studies<br/>Cell Proliferation--drug effects<br/>Cell Size--drug effects<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Immunophenotyping<br/>Male<br/>Microtubules--drug effects<br/>Middle Aged<br/>Mitochondria--drug effects<br/>Models, Biological<br/>Mutation--genetics<br/>Paclitaxel--pharmacology<br/>Peroxisomes--drug effects<br/>Spastic Paraplegia, Hereditary--genetics<br/>Spastin<br/>Stathmin--metabolism<br/>Stem Cells--drug effects<br/>Tubulin--metabolism<br/>Tubulin Modulators--pharmacology<br/>Vinblastine--pharmacology<br/>Young Adult